ICAM-1 Expression in Human Endometrium and Progestin-Only Contraception
Author Information
Author(s): Frederick Schatz, Graciela Krikun, Rebecca N Baergen, Hilary OD Critchley, Edward Kuczynski, Charles J Lockwood
Primary Institution: Yale University School of Medicine
Hypothesis
Does altered expression of ICAM-1 account for neutrophil infiltration in the endometrium during the menstrual cycle and after LTPOC treatment?
Conclusion
The study suggests that ICAM-1 expression by endothelial cells does not explain the influx of neutrophils into the endometrium during the menstrual cycle or LTPOC therapy.
Supporting Evidence
- ICAM-1 was prominently stained in the endometrial endothelium across different menstrual phases.
- The intensity of ICAM-1 staining did not vary significantly with hormonal or inflammatory states.
- Stromal cells showed weak immunoreactivity for ICAM-1, contrasting with previous reports.
Takeaway
The study looked at how a protein called ICAM-1 behaves in the lining of the uterus during different times of the month and after using certain birth control methods, finding it doesn't change much.
Methodology
Endometrial biopsies were taken from women across the menstrual cycle and those on LTPOC treatment, followed by immunohistochemical staining for ICAM-1.
Potential Biases
Potential bias in patient selection and the reliance on immunohistochemical methods.
Limitations
The study did not assess the role of other potential factors influencing neutrophil infiltration.
Participant Demographics
Women aged 28 to 45 with regular menstrual cycles, not using hormonal contraception for six months prior.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website